Benzinga's Top Downgrades

Analysts at Goldman Sachs downgraded Williams Partners LP

from “buy” to “neutral.” The target price for Williams Partners is set to $52. Williams Partners' shares closed at $48.09 yesterday. Analysts at Bank of America downgraded Genomic Health

from “buy” to “neutral.” The target price for Genomic Health has been lowered from $43 to $36. Genomic Health's shares closed at $32.97 yesterday. Analysts at Barclays downgraded Covance

from “equal-weight” to “underweight.” The target price for Covance is set to $55. Covance's shares closed at $78.43 yesterday. KeyBanc downgraded Sanderson Farms

from “buy” to “hold.” Sanderson Farms' shares closed at $68.85 yesterday.